JOURNAL OF GENERAL INTERNAL MEDICINE, a leading publication in the field of internal medicine, is published by Springer and boasts an impressive Q1 rank in internal medicine as of 2023, situating itself prominently at Rank #28 out of 167 in Scopus with an 83rd percentile. Since its inception in 1986, this esteemed journal has been at the forefront of disseminating high-quality research, clinical practices, and healthcare innovations that shape the landscape of internal medicine. The journal is recognized for its original research, systematic reviews, and practice guidelines that are essential for professionals navigating the complexities of patient care and clinical decision-making. With access options available, it serves as a critical resource for researchers, healthcare practitioners, and students alike, facilitating the enhancement of medical knowledge and evidence-based practice globally. The Journal's commitment to excellence is reflected in its ongoing contribution to advancing the field and ensuring that the latest findings reach those who need them most.

Journal of Primary Health Care, published by CSIRO PUBLISHING, is a premier open-access journal dedicated to advancing the field of primary health care since its inception in 2009. With an E-ISSN of 1172-6156, the journal serves as a vital platform for disseminating innovative research and practices that improve health outcomes across diverse populations. Featuring a robust H-index and notable rankings—including Q2 in Family Practice and Q3 in both Medicine (miscellaneous) and Public Health—this journal holds a significant position within the academic community, offering valuable insights to researchers, practitioners, and students alike. By providing open-access options, the Journal of Primary Health Care ensures that its findings are accessible to a global audience, promoting collaboration and knowledge sharing. As we look toward 2024, we invite contributors to be part of this dynamic conversation, addressing the critical issues in primary health care delivery and policy.

Family Medicine and Primary Care Review, published by TERMEDIA PUBLISHING HOUSE LTD, is a significant open-access journal dedicated to advancing the field of primary care and family medicine. Since its inception in 2006, the journal has fostered an environment for the dissemination of innovative research, clinical practices, and reviews relevant to general medicine, securing its place within the Q4 category in the 2023 journal rankings. With an emphasis on accessibility since 2008, it aims to bridge gaps in medical knowledge and practice, contributing to the global conversation on healthcare delivery. Located in Poland, the journal serves as a valuable resource for researchers, healthcare professionals, and students alike, providing insights and developments that shape the future of primary care. With a Scopus rank of #317 out of 636 in the field of general medicine, it stands as a credible source of information for those committed to improving health outcomes in local and international communities.

The JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, published by Walter de Gruyter GmbH, is a reputable peer-reviewed journal dedicated to advancing the field of pediatric endocrinology and metabolism. Since its inception in 1985, this journal has become a vital resource for professionals and researchers, providing insights into the latest advancements, clinical practices, and foundational research in the care of children with endocrine disorders. With a noted Q3 ranking in Endocrinology, Diabetes and Metabolism, and a robust focus on Pediatrics, Perinatology, and Child Health, it addresses important topics such as hormonal imbalances and metabolic syndromes in young populations. Despite its non-open access status, it continues to play an essential role in bridging the knowledge gap within our understanding of children's health and disease, contributing significantly to the progress in this specialized field.

Journal of Endocrinology Metabolism and Diabetes of South Africa, published by Routledge Journals, Taylor & Francis Ltd, serves as a vital platform for advancing research and knowledge dissemination in the fields of endocrinology, metabolism, and diabetes. Since its transition to Open Access in 2012, it has enabled greater accessibility to crucial findings and data, broadening its reach to researchers, practitioners, and students alike. Though its coverage in Scopus was discontinued in 2018, the journal continues to play an important role in fostering discourse in the medical community, as evidenced by its ranking within the 19th and 16th percentiles for Internal Medicine and Endocrinology, diabetes and metabolism, respectively. With its commitment to addressing pressing health issues in South Africa and beyond, this journal remains an invaluable resource for those seeking to understand and tackle the complexities of metabolic diseases.

Obesity Research & Clinical Practice is an esteemed journal published by ELSEVIER SCI LTD, focusing on cutting-edge research and clinical practices related to obesity and its multifaceted impact on health and wellness. With an ISSN of 1871-403X and an E-ISSN of 1878-0318, this journal serves as a vital resource for researchers and practitioners in the fields of Endocrinology, Diabetes and Metabolism and Nutrition and Dietetics. Notably, it holds a Q2 ranking in Endocrinology, Diabetes and Metabolism and a prestigious Q1 ranking in Nutrition and Dietetics for 2023, reflecting its influence and quality within the scientific community. The journal features a broad scope of research topics encompassing clinical findings, epidemiological studies, and therapeutic advancements in obesity treatment, aiming to improve health outcomes globally. Submissions are encouraged from diverse disciplines, ensuring a dynamic and multidisciplinary approach to tackling obesity-related challenges. Given its convergence of years from 2007 to 2024, Obesity Research & Clinical Practice stands as a prominent platform for disseminating valuable knowledge, insights, and groundbreaking research in this pressing area of public health.

DM DISEASE-A-MONTH is a leading monthly journal published by MOSBY-ELSEVIER, dedicated to disseminating pivotal research and insights across the spectrum of general medicine. With a history spanning from 1954 to 2024, this journal has established itself as a key resource within the field, reflecting its commitment to advancing medical knowledge and practice. As evidenced by its impressive Scopus ranking—currently at #79 out of 636 in General Medicine and falling within the 87th percentile—this journal occupies a prominent position in the medical literature landscape. Although not an open-access publication, DM DISEASE-A-MONTH continues to serve a diverse audience of researchers, healthcare professionals, and medical students, providing valuable updates on recent advances in medicine and enabling its readers to stay informed about emerging trends and critical health issues. Its current Q2 category ranking in the 2023 Medical (miscellaneous) field further underscores its relevance and impact, making it an essential addition to the library of any medical practitioner or researcher.

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo is a pivotal journal dedicated to advancing the fields of endocrinology, diabetes, and metabolism. Published by the esteemed SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDM, this journal serves as a platform for the dissemination of high-quality research, clinical studies, and innovative practices within these related disciplines. With a commitment to providing insightful and impactful content, the journal aims to foster knowledge sharing among researchers, healthcare professionals, and students interested in the latest developments in endocrine disorders and metabolic diseases. Although currently not open access, the journal's comprehensive approach and rigorous peer-review process ensure that it remains a respected source of information for its readers in Portugal and beyond. With its address rooted in the heart of Lisbon, the Revista Portuguesa de Endocrinologia Diabetes e Metabolismo plays a vital role in enhancing the understanding and treatment of endocrine and metabolic conditions in the modern healthcare landscape.

Medicina de Familia-SEMERGEN is a pivotal Spanish journal focused on the field of family medicine and public health, published by the esteemed Elsevier. With an ISSN of 1138-3593 and an E-ISSN of 1578-8865, this journal provides a platform for researchers and practitioners to disseminate innovative studies, clinical practices, and case reports that advance the understanding of family healthcare dynamics. As of 2023, it is categorized in Q3 in Family Practice and Q4 in Public Health, reflecting its significant contributions to the respective fields. The journal is indexed in Scopus, holding ranks of 31/56 and 473/665 for family practice and public health respectively, showcasing its relevance in academic discourse. While maintaining a commitment to quality research, Medicina de Familia-SEMERGEN remains accessible for professionals seeking to improve patient outcomes in family medicine, making it an essential resource for anyone in the health domain.

Primary Care Diabetes is a leading journal published by ELSEVIER SCI LTD, focusing on the intersection of diabetes care, endocrinology, and family medicine. Since its inception in 2007, the journal has made significant contributions to the field, achieving notable rankings in various categories, such as Q2 in Endocrinology, Diabetes and Metabolism, Q1 in Family Practice, and Q2 in Internal Medicine, as well as Nutrition and Dietetics for 2023. With an ISSN of 1751-9918 and an E-ISSN of 1878-0210, it serves as an essential resource for researchers, healthcare professionals, and students dedicated to advancing knowledge and practice in primary diabetes care. The journal's strong Scopus rankings reflect its commitment to publish high-quality research, fostering clinical practice improvements and enhanced patient outcomes. Although not open access, its articles are pivotal for anyone looking to stay ahead in the dynamic and vital domain of diabetes management.